Treace Medical Concepts I...

NASDAQ: TMCI · Real-Time Price · USD
6.95
0.05 (0.72%)
At close: Aug 14, 2025, 3:59 PM
6.95
0.00%
After-hours: Aug 14, 2025, 04:20 PM EDT

Treace Medical Concepts Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
209.36M 187.12M 141.84M 94.42M
Cost of Revenue
41.09M 35.18M 27.52M 17.83M
Gross Profit
168.26M 151.94M 114.31M 76.59M
Operating Income
-55.69M -51.43M -34.84M -16.51M
Interest Income
4.88M 6.73M 1.31M 18K
Pretax Income
-55.74M -49.53M -42.81M -20.55M
Net Income
-55.74M -49.53M -42.81M -20.55M
Selling & General & Admin
203.36M 187.93M 137.57M 83.84M
Research & Development
20.59M 15.44M 13.58M 10.2M
Other Expenses
n/a n/a -1.99M -938K
Operating Expenses
223.95M 203.37M 149.16M 93.1M
Interest Expense
5.26M 5.17M 4.4M 4.06M
Selling & Marketing Expenses
147.64M 140.89M 104.57M 65.41M
Cost & Expenses
265.05M 238.55M 176.68M 110.93M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
62.11M 60.85M 55.28M 54.18M
Shares Outstanding (Diluted)
62.11M 60.85M 55.28M 54.18M
EPS (Basic)
-0.9 -0.81 -0.77 -0.38
EPS (Diluted)
-0.9 -0.81 -0.77 -0.38
EBITDA
-42.07M -39.01M -36.28M -15.81M
EBIT
-50.49M -44.36M -38.42M -16.49M
Depreciation & Amortization
8.42M 5.35M 2.13M 685K